Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Structural Evolution of the Pharmaceutical Peptide Octreotide upon Controlled Relative Humidity and Temperature Variation

Version 1 : Received: 11 April 2024 / Approved: 14 April 2024 / Online: 15 April 2024 (11:34:32 CEST)

How to cite: Athanasiadou, M.; Papaefthymiou, C.; Kontarinis, A.; Spiliopoulou, M.; Koutoulas, D.; Konstantopoulos, M.; Kafetzi, S.; Barlos, K.; Barlos, K.K.; Dadivanyan, N.; Beckers, D.; Degen, T.; Fitch, A.N.; Margiolaki, I. Structural Evolution of the Pharmaceutical Peptide Octreotide upon Controlled Relative Humidity and Temperature Variation. Preprints 2024, 2024040875. https://doi.org/10.20944/preprints202404.0875.v1 Athanasiadou, M.; Papaefthymiou, C.; Kontarinis, A.; Spiliopoulou, M.; Koutoulas, D.; Konstantopoulos, M.; Kafetzi, S.; Barlos, K.; Barlos, K.K.; Dadivanyan, N.; Beckers, D.; Degen, T.; Fitch, A.N.; Margiolaki, I. Structural Evolution of the Pharmaceutical Peptide Octreotide upon Controlled Relative Humidity and Temperature Variation. Preprints 2024, 2024040875. https://doi.org/10.20944/preprints202404.0875.v1

Abstract

Abstract Octreotide is the first synthetic peptide hormone, consisted of eight amino acids, that mimics the activity of somatostatin, a natural hormone in the body. During the past decades, advanced instrumentation and crystallographic software established X-ray Powder Diffraction (XRPD) as a valuable tool for extracting structural information of biological macromolecules. The latter was demonstrated by the successful structural determination of octreotide at a remarkably high d-spacing resolution (1.87 Å) (PDB code: 6vc1). This study focuses on the response of octreotide to different humidity levels and temperatures, with a particular focus on the stability of the polycrystalline sample. XRPD measurements were accomplished employing an Anton Paar MHC-trans humidity-temperature chamber installed within a laboratory X’Pert Pro diffractometer (Malvern Panalytical). The chamber is employed to control and maintain precise humidity and temperature levels of samples during XRPD data collection. Pawley analysis of the collected data sets revealed that the octreotide polycrystalline sample is remarkably stable and no structural transitions were observed. The compound retains its orthorhombic symmetry (space group: P212121, a = 18.57744(4) Å, b = 30.17338(6) Å, c = 39.70590(9) Å, d~ 2.35 Å). However, a characteristic structural evolution in terms of lattice parameters and volume of the unit-cell is reported mainly upon controlled relative humidity variation. In addition, an improvement of signal-to-noise ratio in the XRPD data under a cycle of dehydration/rehydration is reported. These results underline the importance of considering the impact of environmental factors, as humidity and temperature, in the context of structure-based drug design, thereby contributing to the development of more effective and stable pharmaceutical products.

Keywords

humidity variation; temperature variation; X-ray crystallography; peptides; polymorphism; octreotide; drug stability; in situ X-ray powder diffraction

Subject

Biology and Life Sciences, Biochemistry and Molecular Biology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.